Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 75
| Report ID | 208030 |
| Drug Identification Number | 02341697 |
| Brand name | GD-DICLOFENAC/MISOPROSTOL 75 |
| Common or Proper name | GD-DICLOFENAC/MISOPROSTOL 75 |
| Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
| Strength(s) | 200MCG 75MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 250's |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-11-03 |
| Actual start date | |
| Estimated end date | 2024-01-31 |
| Actual end date | 2024-02-21 |
| Shortage status | Resolved |
| Updated date | 2024-02-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-02-22 | English | Compare |
| v7 | 2024-02-21 | French | Compare |
| v6 | 2024-02-21 | English | Compare |
| v5 | 2023-12-19 | French | Compare |
| v4 | 2023-12-19 | English | Compare |
| v3 | 2023-11-04 | English | Compare |
| v2 | 2023-10-25 | French | Compare |
| v1 | 2023-10-25 | English | Compare |
Showing 1 to 8 of 8